What antihypertensive (blood pressure medication) is recommended for postpartum hypertension following a cesarean section (CS)?

Postpartum Hypertension Management After Cesarean Section

First-Line Oral Antihypertensives for Maintenance Therapy

For postpartum hypertension following cesarean section, nifedipine extended-release, amlodipine, enalapril, or labetalol are recommended as first-line agents, with calcium channel blockers (nifedipine or amlodipine) preferred due to once-daily dosing, better adherence, and potentially superior efficacy compared to labetalol in the postpartum period. 1

Preferred First-Line Options:

• Nifedipine extended-release (30-60 mg once daily): Offers once-daily dosing which improves adherence, is safe with breastfeeding, and aligns with standard hypertension guidelines 1

• Amlodipine (5-10 mg once daily): Provides once-daily dosing, is safe during breastfeeding, and recent evidence demonstrates noninferiority to nifedipine ER with potentially fewer discontinuations due to side effects 1, 2

• Enalapril (5-20 mg once daily): Once-daily ACE inhibitor that is safe during breastfeeding (unless neonate is premature or has renal failure), though requires documented contraception plan due to teratogenicity risk in future pregnancies 1, 3

Alternative First-Line Option:

• Labetalol (200-800 mg twice daily or more frequently): Commonly used but requires twice-daily or more frequent dosing due to accelerated drug metabolism postpartum, which is a major disadvantage for adherence 1. Recent data suggest labetalol may be less effective in the postpartum period compared to calcium channel blockers and may be associated with higher readmission risk 1. Contraindicated in reactive airway disease 1.

---

Acute Management of Severe Hypertension (≥160/110 mmHg)

Blood pressure ≥160/110 mmHg sustained for more than 15 minutes constitutes a hypertensive emergency requiring treatment within 30-60 minutes to prevent stroke and other end-organ damage. 1, 4

First-Line Acute Treatments:

• Oral immediate-release nifedipine (10-20 mg): Fastest-acting option when IV access is unavailable, achieves treatment success in ~84-100% of cases 4, 5, 6. Do not use short-acting nifedipine for maintenance therapy as it can cause uncontrolled hypotension 3.

• IV labetalol: Start with 20 mg IV bolus, followed by 40-80 mg every 10 minutes until desired effect or maximum cumulative dose of 300 mg 4, 5

• IV hydralazine: Start with 5 mg IV initially, then 5-10 mg IV every 30 minutes as needed 4, 5. Note that IV hydralazine is no longer the drug of choice as it is associated with more perinatal adverse effects than other agents 1.

• IV nicardipine infusion: Start at 5 mg/h, increase by 2.5 mg/h every 5-15 minutes to maximum of 15 mg/h 4

Target Blood Pressure:

• Reduce mean arterial pressure by 15-25% 4
• Target systolic BP 140-150 mmHg and diastolic BP 90-100 mmHg 1, 4

---

Critical Medications to AVOID Postpartum

• Methyldopa: Should be avoided postpartum due to increased risk of postpartum depression 1, 3

• Diuretics (furosemide, hydrochlorothiazide, spironolactone): May reduce milk production, though can be considered at lower doses if needed for BP recovery after hypertensive disorders of pregnancy 1, 3

• Atenolol: Should not be used due to risk of fetal growth restriction 1

• NSAIDs: Avoid for postpartum analgesia in women with preeclampsia, especially those with renal disease, placental abruption, acute kidney injury, or other risk factors, as NSAIDs can worsen hypertension 4, 3

---

Critical Monitoring Considerations

Timing of Blood Pressure Peak:

• Blood pressure typically peaks 3-6 days postpartum, which is when most women have been discharged home and when the majority of hypertension-related maternal deaths occur, including from stroke and cardiomyopathy 4, 3, 7

• Close BP monitoring is essential for at least 3 days postpartum, with continued vigilance through the first week 4, 3

• Do not discharge patients without a clear BP monitoring plan for the critical first 3-7 days 4

Home Monitoring:

• Home blood pressure monitoring with self-titration of antihypertensive medication is appropriate as BP will normalize within 3 months postpartum in most cases 4, 3

---

Special Considerations

Concurrent Magnesium Sulfate:

• Avoid concomitant administration of calcium channel blockers (nifedipine) with magnesium sulfate due to risk of synergistic hypotension 3

Reduced Ejection Fraction:

• If mild reduction in ejection fraction (40-50%) is present, consider combination therapy with β-blocker plus ACE inhibitor or ARB, adopting heart failure guidelines 1

Contraception Planning:

• Document contraception plan, especially when prescribing ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists due to teratogenicity risk 1, 4

---

Long-Term Follow-Up

• All women with hypertension in pregnancy should have BP and urine checked at 6 weeks postpartum 4

• Women with pregnancy-related hypertensive disorders are at significantly increased risk of developing chronic hypertension (nearly 4-fold), stroke (more than 2-fold), ischemic heart disease (more than 2-fold), and thromboembolic disease later in life 1, 4, 3

• Cardiovascular risk assessment and lifestyle modifications are recommended for all women with pregnancy-related hypertensive disorders 1, 4, 3

• Women with persisting hypertension or proteinuria at 6 weeks should be referred to a specialist 4